Sedana Medical receives additional patent for AnaConDa
Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has been granted another patent regarding the medical device AnaConDa. The technology that the patent protects enables a reduction of the so-called dead space with the help of inserts.The patent is central to the continued development of inhaled sedation. Launched in 2017, the AnaConDa-S has a dead space of 50 ml instead of 100 ml, as the first AnaConDa model. The goal is to reduce the dead space of AnaConDa-S by 20 percent down to 40 ml. A reduction in dead space for ventilated patients is always desirable in